Previous Episode: Humm Group (ASX:HUM) launches digital BNPL card
03 Jun 2021 - Regenerative medicine developer Mesoblast (ASX:MSB) has reported a downturn in earnings, as revenue plunged during the three months ended 31 March this year.
03 Jun 2021 - Regenerative medicine developer Mesoblast (ASX:MSB) has reported a downturn in earnings, as revenue plunged during the three months ended 31 March this year.